NT_1170x120_1-11-18

House Committee on Oversight and Government Reform

Video: Mylan CEO testifies at EpiPen hearing

Video: Mylan CEO testifies at EpiPen hearing

Mylan CEO Heather Bresch gave testimony at a hearing Wednesday afternoon by the House Committee on Oversight and Government Reform over the sharp price hike for the EpiPen epinephrine auto-injector since the company acquired the product in 2007. The EpiPen is used for treating anaphylaxis, a potentially life-threatening allergic reaction. Committee chairman Jason Chaffetz (R.,

NCPA to Congress: More scrutiny of PBMs needed

NCPA to Congress: More scrutiny of PBMs needed

ALEXANDRIA, Va. — In comments to Congress, the National Community Pharmacists Association called for more oversight of pharmacy benefit management (PBM) companies. NCPA said payers, pharmacy patients and pharmacists could see “tangible benefits” from increased transparency into PBM business practices and potential conflicts of interests. The association submitted its comments to the House Committee on